Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TriSalus Infusion System

K-Number: K193107 · 2019-12-03

Decision Date2019-12-03
Product CodeKRA
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

TriSalus Infusion System is a medical device manufactured by Trisalus Life Sciences. It received FDA 510(k) clearance on 2019-12-03 under approval number K193107. The device is classified under product code KRA. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TriSalus Infusion System?

TriSalus Infusion System is a medical device that received FDA 510(k) clearance on 2019-12-03. It is manufactured by Trisalus Life Sciences. The 510(k) number is K193107.

When was TriSalus Infusion System approved by the FDA?

TriSalus Infusion System received FDA 510(k) clearance on 2019-12-03, under approval number K193107.

What company makes TriSalus Infusion System?

TriSalus Infusion System is manufactured by Trisalus Life Sciences.

What is the FDA product code for TriSalus Infusion System?

The FDA product code for TriSalus Infusion System is KRA.

Related Clinical Trials

Other Devices by Trisalus Life Sciences

Related Devices (Code: KRA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.